Get the Stockscreener App
0.1393
0.50%
-0.0007
Azitra Inc stock is traded at $0.1393, with a volume of 1.04M.
It is down -0.50% in the last 24 hours and up +8.24% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.14
Open:
$0.146
24h Volume:
1.04M
Relative Volume:
0.09
Market Cap:
$2.26M
Revenue:
$7,500
Net Income/Loss:
$-10.96M
P/E Ratio:
-0.0607
EPS:
-2.2943
Net Cash Flow:
$-11.41M
1W Performance:
+3.19%
1M Performance:
+8.24%
6M Performance:
-30.28%
1Y Performance:
-6.51%
1-Day Range:
$0.1357
$0.146
1-Week Range:
$0.1287
$0.15
52-Week Range:
$0.10
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.1393 | 2.19M | 7,500 | -10.96M | -11.41M | -2.2943 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Azitra Inc Stock (AZTR) Latest News
Azitra (AZTR): Nantahala Capital reports 6.48M-share, 9.99% beneficial stake - Stock Titan
Nantahala Capital Partners (AZTR) discloses 8.40% beneficial stake in Azitra - Stock Titan
Azitra, Inc. (AZTR) stock price, news, quote and history - Yahoo Finance Australia
Azitra Reports Q2 Net Loss of $3.3 Million - Quiver Quantitative
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates - PR Newswire
Azitra (NYSE American: AZTR) posts Q2 2026 loss but lifts equity above NYSE limits - Stock Titan
Azitra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Azitra reports Q2 2026 results, advances skin t... - Pluang
Why Is AZTR Stock Rising Today? - stocktwits.com
Azitra Inc (AZTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Azitra Inc (AZTR) Stock News Today - TradingKey
AZTR|Azitra Inc|Price:0.133|Chg%:+0.002 - TradingKey
Azitra Inc Q1 2026 Earnings: Deep EPS Miss Raises Concern as Revenue Remains AbsentHigh Growth Earnings - dars.gov.et
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar - TipRanks
Azitra Inc (AZTR) Income Statement - TradingKey
Azitra Inc Revenue Breakdown – AMEX:AZTR - TradingView
Azitra Inc (AZTR) Cash Flow - TradingKey
AZTR|Azitra Inc|Price:0.130|Chg%:+0.003 - TradingKey
Azitra Inc (AZTR) Balance Sheet - tradingkey.com
Azitra Inc (AZTR) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Azitra Inc (AZTR) Institutional Confidence - TradingKey
Azitra Inc (AZTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Azitra Inc (AZTR) Tests Key Support at $0.12 After Modest DeclineIPO Entry Watch - dars.gov.et
Azitra Inc (AZTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Azitra Inc (AZTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Azitra Inc (AZTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Azitra Inc (AZTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Azitra Inc (AZTR) Earnings Date & Reports & Earnings News - TradingKey
Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending - MSN
Enterprise value to EBIT forward of Azitra Inc – AMEX:AZTR - TradingView
Price to sales forward of Azitra Inc – AMEX:AZTR - TradingView
Why are shares of Azitra rising? - MSN
Enterprise value to revenue forward of Azitra Inc – AMEX:AZTR - TradingView
Price to earnings forward of Azitra Inc – AMEX:AZTR - TradingView
AzitraAnnounces Breakthrough Ex Vivo Resul - Moomoo
Azitra, Inc. (NYSE American: AZTR) shows dose-linked skin elasticity gains - Stock Titan
/C O R R E C T I O N -- Azitra, Inc./ - AOL.com
Azitra's new skin treatment shows promise in im... - Pluang
AZTR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Shares DeclineProfit Growth Outlook - dars.gov.et
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting - AOL.com
AZTR Q1 2026 Earnings: Major EPS Miss of -$0.25 vs -$0.01 Estimate; Stock Drops 9.3% on No RevenueEPS Growth Report - DonanımHaber
Azitra Inc Actuals & Estimates (AMEX:AZTR) - TradingView
Dauntless Investment Group buys stake in Azitra (AZTR) — 9.58% disclosed - Stock Titan
AZTR Forecast — Price Target — Prediction for 2027 - TradingView
Francisco D. Salva Discloses Investment at Azitra, Inc. with 9.99% Stake - TradingView
$Azitra (AZTR.US)$ - Moomoo
[SCHEDULE 13D] Azitra, Inc. Major Shareholder Acquisition (>5%) - Stock Titan
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket - Sahm
Form 13G Azitra For: 22 June By Investing.com - Investing.com Australia
Stonepine group discloses 1.74M-share stake in Azitra (NASDAQ: AZTR) with 9.9% cap - Stock Titan
$Azitra (AZTR.US)$ tq aztr - Moomoo
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Cap:
|
Volume (24h):